Results 31 to 40 of about 289,605 (341)
Archives of Medical Science, 2019 Introduction Medullary breast cancer (MdBC) is an uncommon type of breast cancer representing 1–7% of all cases. It is characterized by the occurrence of many histopathological features associated with a high grade of malignancy.
Michał P. Budzik +6 more
doaj +1 more source
Progress of Immunotherapy and Its Application in Triple Negative Breast Cancer
Zhongliu Fangzhi Yanjiu, 2020 In recent years, potential new therapeutic options have been yielded for the immunotherapy of invasive cancers. The most important breakthrough in breast cancer research today is to understand the immune features and profiles of triple negative breast ...
ZHENG Hongmei +6 more
doaj +1 more source
Technology in Cancer Research & Treatment, 2023 Breast cancer is the most common malignancy and the second most common cause of cancer-related mortality in women. Triple-negative breast cancers do not express estrogen receptors, progesterone receptors, or human epidermal growth factor receptor 2 and ...
Boya Lu MD +3 more
doaj +1 more source
Frontiers in Molecular Biosciences, 2022 Triple-negative breast cancer (TNBC) is a kind of breast cancer that lacks estrogen, progesterone, and human epidermal growth factor receptor 2. This cancer is responsible for more than 15–20% of all breast cancers and is of particular research interest ...
N. Almansour
semanticscholar +1 more source
Atezolizumab and Nab‐Paclitaxel in Advanced Triple‐Negative Breast Cancer
New England Journal of Medicine, 2018 Background Unresectable locally advanced or metastatic triple‐negative (hormone‐receptor–negative and human epidermal growth factor receptor 2 [HER2]–negative) breast cancer is an aggressive disease with poor outcomes.
P. Schmid +17 more
semanticscholar +1 more source
A molecular approach to triple-negative breast cancer: targeting the Notch signaling pathway [PDF]
Einstein (São Paulo)Introduction Triple-negative breast cancer is an aggressive subtype of breast cancer characterized by the absence of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression. This phenotype renders triple-negative
Isabele Pardo +3 more
doaj +1 more source
Discover Oncology, 2023 Purpose Triple-negative breast cancer continues to be one of the leading causes of death in women, making up 7% of all cancer deaths. Tumor-treating electric fields are low-energy, low-frequency oscillating electric fields that induce an anti ...
Austin R. Smothers +6 more
doaj +1 more source
Triple negative breast cancer: Pitfalls and progress
npj Breast Cancer, 2022 Triple negative breast cancer (TNBC) is characterized by the lack of estrogen and progesterone receptor expression and lacks HER2 overexpression or gene amplification.
P. Zagami, L. Carey
semanticscholar +1 more source
Breast Cancer: Basic and Clinical Research, 2009 In the current study, we sought to examine the effects of curcumin in a specific type of breast cancer called triple negative breast cancer. These cancers lack expression of the estrogen and progesterone receptors and do not over-express HER2.
Danica L. Rowe +3 more
doaj +2 more sources
Triple-Negative Breast Cancer [PDF]
The American Journal of Pathology, 2017 Triple-negative breast cancer (TNBC) is an aggressive form of breast cancer that differs in epidemiology, risk factors, and prognosis from other types of breast cancer. The challenge in treating TNBC lies in the lack of targeted therapies currently available. Chemotherapy remains the only treatment option presently. Current research efforts are focused
Jonathan D. Marotti +3 more
openaire +2 more sources